Docebo Inc. (TSE:DCBO – Get Free Report) insider Lauren Anne Tropeano sold 367 shares of the firm’s stock in a transaction that occurred on Monday, September 14th. The stock was sold at an average price of C$33.60, for a total value of C$12,331.20. Following the completion of the sale, the insider directly owned 2,236 shares in the company, valued at approximately C$75,129.60. This trade represents a 14.10% decrease in their position.
Docebo Trading Down 2.5%
TSE:DCBO opened at C$34.06 on Wednesday. The firm has a market capitalization of C$849.73 million, a P/E ratio of 29.62 and a beta of 0.28. The business has a 50 day simple moving average of C$30.91 and a 200 day simple moving average of C$27.00. The company has a debt-to-equity ratio of -30,643.19, a current ratio of 0.76 and a quick ratio of 3.25. Docebo Inc. has a 12-month low of C$19.87 and a 12-month high of C$42.52.
Docebo (TSE:DCBO – Get Free Report) last issued its earnings results on Friday, August 7th. The company reported C$0.50 earnings per share for the quarter. The firm had revenue of C$97.54 million for the quarter. Docebo had a return on equity of 114.70% and a net margin of 13.23%. Equities research analysts predict that Docebo Inc. will post 1.6842684 EPS for the current year.
Analysts Set New Price Targets
Check Out Our Latest Research Report on DCBO
About Docebo
Docebo (NASDAQ: DCBO; TSX: DCBO) is the enterprise platform for the AI-era workforce, unifying skills intelligence, learning, and knowledge in one closed loop. Docebo gives organizations the tools to close skills gaps, develop talent, and perform at their best in an AI-driven world.
Recommended Stories
- Five stocks we like better than Docebo
- Running on Empty: 3 Energy Plays for Europe’s Deep Freeze
- 3 Healthcare Stocks for 3 Stages of Life
- Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid
- MarketBeat’s Most Downgraded Stocks in Q3: 2 Look Cheap, 1 Looks Risky
Receive News & Ratings for Docebo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docebo and related companies with MarketBeat.com's FREE daily email newsletter.
